Unknown

Dataset Information

0

P22 Patient-level meta-analysis of efficacy and safety from STRIVE and ReSTORE: randomized, double-blinded, multicentre Phase 2 and Phase 3 trials of rezafungin in the treatment of candidaemia and/or invasive candidiasis

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC9848852 | biostudies-literature | 2023 Jan

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Rezafungin versus caspofungin for patients with candidaemia or invasive candidiasis in the intensive care unit: pooled analyses of the ReSTORE and STRIVE randomised trials.
| S-EPMC11520665 | biostudies-literature
Unknown P27 Rezafungin treatment of candidaemia and invasive candidiasis: outcomes stratified by baseline renal function—analysis of the Phase 2 + Phase 3 trials
| S-EPMC10266181 | biostudies-literature
Unknown P28 Rezafungin efficacy and safety in immunocompromised patients: sub-analyses of the Phase 3 trial in treatment of candidaemia and invasive candidiasis
| S-EPMC10266150 | biostudies-literature
Unknown Rezafungin Versus Caspofungin in a Phase 2, Randomized, Double-blind Study for the Treatment of Candidemia and Invasive Candidiasis: The STRIVE Trial.
| S-EPMC8662762 | biostudies-literature
Unknown 637. Outcomes by Body Mass Index (BMI) in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin
| S-EPMC7777904 | biostudies-literature
Unknown 1284. Outcomes by Baseline Pathogens and Susceptibility in the STRIVE Phase 2 Trial of Once-Weekly Rezafungin for Treatment of Candidemia and Invasive Candidiasis Compared with Caspofungin
| S-EPMC7776548 | biostudies-literature
Unknown Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis: Results from the Double-blind, Randomized, Phase 3 ReSTORE Trial Including the China Extension Study.
| S-EPMC12461853 | biostudies-literature
Unknown Efficacy and Safety of Rezafungin Versus Caspofungin for the Treatment of Candidemia and Invasive Candidiasis in a China Cohort of a Double-Blind, Randomised, Phase 3 Trial (ReSTORE China).
| S-EPMC12589930 | biostudies-literature
Unknown Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
| S-EPMC3510306 | biostudies-literature
Unknown Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia.
| S-EPMC8092522 | biostudies-literature